BIO.News Newsletter

Two hearings yesterday highlighted incredible biopharmaceutical advances and how policy can help or hinder access to them. Plus, BIO Impact registration is now open—here’s what you need to know. (741 words, 3 minutes, 42 seconds)

The AIM for Climate Summit wraps up in Washington, D.C., with calls for investment in the bioeconomy. Plus, we’re watching for ticks—and new Lyme disease treatments and vaccines. (677 words, 3 minutes, 23 seconds)

On today’s new episode of the I am BIO Podcast, FDA Commissioner Dr. Robert Califf explains why misinformation is deadly. Plus, BIO CEO Rachel King explains why we need to help SAF take off. (547 words, 2 minutes, 44 seconds)

Today, we start the week with a global view—with news from the U.N. on hunger and COVID-19, and the role of biotech in ending both. (631 words, 3 minutes, 9 seconds)

What happened during yesterday’s hearing on PAHPA reauthorization? Why are policymakers undermining one of the FDA’s most successful programs? We answer these questions and more. (678 words, 3 minutes, 23 seconds)

Exciting news from BIO members today, as the FDA has approved the first RSV vaccine in the U.S. for older adults, and Eli Lilly has promising news about its Alzheimer’s drug. Meanwhile, a new analysis asks: who will pay for transformative therapies? (640 words, 3 minutes, 12 seconds)

We recap what happened at yesterday’s markup of PBM legislation, and look at how gene editing could eliminate allergens from eggs. (495 words, 2 minutes, 28 seconds)

USTR released its annual report on global IP protections—we take a closer look at what’s in it, and BIO’s take. Plus, we tell you why you should know about the lablab bean. (547 words, 2 minutes, 44 seconds)

Kicking off a new week and month with a recap of Friday’s AMR hearing, and a look at new biotech shirts on sale now at lululemon. (565 words, 2 minutes, 49 seconds)

Busy Friday: the PASTEUR Act was reintroduced yesterday, and a hearing today will look at the emerging threat of AMR. Plus, six things we’re watching on PBMs and a recap of yesterday’s hearing on patents and IP. (845 words, 4 minutes, 13 seconds)